Deciphering Congenital Heart Disease Using Human Induced Pluripotent Stem Cells

Area of Science:

• Cardiovascular Research
• Stem Cell Biology
• Developmental Biology

Background:

• Congenital heart disease (CHD) is a primary cause of mortality from birth defects, with complex underlying mechanisms.
• Existing animal models present limitations due to interspecies variability, hindering research progress.
• There is a critical need for advanced, human-specific models to study CHD pathogenesis.

Purpose of the Study:

• To highlight the utility of human induced pluripotent stem cells (iPSCs) for modeling congenital heart disease.
• To discuss the advancements in differentiating iPSCs into cardiovascular lineages and enhancing cell maturity.
• To establish iPSCs and cardiac organoids as a foundation for dissecting CHD mechanisms and translational research.

Main Methods:

• Utilizing human induced pluripotent stem cells (iPSCs) for patient-specific disease modeling.
• Developing and refining protocols for iPSC differentiation into various cardiovascular cell types.
• Creating three-dimensional (3D) cardiac organoids from iPSCs to mimic cardiac physiology.
• Enhancing the maturity and functionality of iPSC-derived cardiovascular cells.

Main Results:

• iPSCs provide a renewable source of patient-specific cells for cardiovascular research.
• Protocols have been established to generate diverse cardiovascular lineages from iPSCs.
• 3D cardiac organoids derived from iPSCs offer a more physiologically relevant model system.
• Improved cell maturity and functionality have been achieved in iPSC-derived cardiovascular cells.

Conclusions:

• Human iPSCs represent a significant advancement in creating effective and reproducible models for congenital heart disease.
• iPSC-based cardiac organoids provide a powerful platform for mechanistic dissection of CHD.
• This approach lays the groundwork for future precision medicine and translational research in CHD.
• The use of iPSCs overcomes limitations of traditional animal models in CHD research.